More than 80 million Americans with low incomes were receiving health coverage through the federal-state program in January. The program now covers nearly 1 in 4 people nationwide.
Federal officials say that some of the money changing hands has corrupted doctors and endangered patients.
HCA charges patients an “activation fee” of up to $50,000 for trauma teams at centers located in half its 179 hospitals — and they often don’t need trauma care, an analysis of insurance claims data shows.
Health care insiders get surprise medical bills, too. One of them shares tips for writing an insurance appeal.
Agricultural workers living in employer-owned housing can have trouble getting health care. It’s symptomatic of bigger gaps in worker protections that the pandemic spotlighted, say proponents of a newly passed Colorado bill for farmworker rights.
Phone visits became an option for many Medicare and Medicaid patients during the pandemic. Now policymakers are deciding whether they’re worth the money.
The federal approval of a controversial drug to treat Alzheimer’s disease has reignited the debate over drug prices and the way the Food and Drug Administration makes decisions. Meanwhile, President Joe Biden seeks to gain goodwill overseas as he announces the U.S. will provide 500 million doses of covid vaccine to international health efforts. Sarah Karlin-Smith of the Pink Sheet, Margot Sanger-Katz of The New York Times and Joanne Kenen of Politico join KHN’s Julie Rovner to discuss these issues and more. Also, Rovner interviews Chiquita Brooks-LaSure, the new administrator of the Centers for Medicare & Medicaid Services. And to mark the podcast’s 200th episode, the panelists discuss what has surprised them most and least over the past four years.
Safety-net clinics especially are bracing for how the drugmaker’s policy shift could reduce their budgets and hamstring their ability to provide care to an at-risk population.
Direct primary care and health care sharing ministries can offer people more accessible or cheaper health care options, but they lack the benefits of traditional insurance and aren’t regulated.
When estimating how well a patient’s kidneys are working, doctors frequently turn to an equation that depends on a question: Is the patient Black? Kidney experts are now debating how to remove the race adjustment and whether the question is a function of sound science. It’s considered just the first step in dismantling institutional racism in kidney care.